Analysis
Chemistry Ventures is raising $500 million for its second fund, according to an SEC filing spotted July 7, up sharply from the $350 million it raised for its debut vehicle roughly two years ago. The Wall Street Journal reports the new fund is already oversubscribed and expected to close soon.
The firm was founded by Mark Goldberg (ex-Index Ventures), Ethan Kurzweil (ex-Bessemer) and Kristina Shen (ex-Andreessen Horowitz), and invests at the early stage across AI infrastructure and application startups. Launching with instant brand recognition from three well-known individual investors is itself a template that's become common in the 2024-2026 cycle, alongside similar spinout funds from Thrive, General Catalyst and Conviction.
The timing matters: Chemistry's raise lands in the same week Recast Capital managing director Sara Zulkosky warned that 80% of US venture capital now flows to rounds of $500 million or more spread across just 29 companies -- a concentration that early-stage specialist funds like Chemistry are implicitly betting reverses, or at least that enough breakout companies still get discovered pre-megaround to make the strategy work.
For LPs, a quick, oversubscribed close on a fund nearly 43% larger than its predecessor -- without yet having a long track record to point to -- is itself a data point about how much capital is chasing access to any recognizable early-stage AI brand right now, regardless of realized returns.
